Full Press Release Details
OF Fifth EXTENSION OF letter of Lock-Up Undertaking
References are made in this
forth extension of the letter of lock-up undertaking (this "Fifth Extension of Lock-Up Undertaking") to:
For good and valuable consideration
received by the Optionee from the Company, the Optionee hereby agrees to enter into this Fifth Extension of Lock-Up Undertaking to extend
the Lock-Up Undertakings for an additional twelve months until April 20, 2027, except that during the term of this Fifth Extension of
the Lock-Up Undertaking, the Optionee may offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any
option or contract to sell, grant any option, right or warrant for the sale of, or otherwise transfer or dispose of up to %
of the Options that have been vested as of the date hereof (and the shares issued upon exercise of such Options).
The laws of New York shall govern
the interpretation, validity, administration, enforcement, and performance of the terms of this Fifth Extension of Lock-Up Undertaking,
regardless of the law that might be applied under principles of conflicts of laws.
remainder of this page is intentionally left blank]
Witness Whereof, the Optionee has executed this letter agreement as of the date first set forth above.
_______________________________
Regencell Bioscience Holdings Limited
_______________________________
Chief Executive Officer
Signature Page of Fifth Extension of Letter of